Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.

Cancers (Basel) · 2017 · PMC5483886 · PMID 28604629

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Despite distinct mechanisms of drug action, there may be significant cross-resistance between abiraterone and enzalutamide [ 41 , 42 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.